Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vacci... Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. Mehr anzeigen
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today announced results from the Phase 3 LEAP-015 trial evaluating KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its fourth-quarter and full-year 2024 sales and earnings conference call with institutional investors and...
GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males Merck (NYSE: MRK), known as MSD outside of the United States and Canada...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, executive vice president...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -5.01 | -4.97813990461 | 100.64 | 100.64 | 95.15 | 15329533 | 96.66377526 | CS |
| 4 | -3.87 | -3.88944723618 | 99.5 | 102.97 | 95.15 | 9728617 | 98.9000751 | CS |
| 12 | -6.08 | -5.97777996264 | 101.71 | 105.0681 | 94.48 | 11434367 | 99.8782072 | CS |
| 26 | -29.39 | -23.5082386818 | 125.02 | 128.73 | 94.48 | 10493571 | 107.03136901 | CS |
| 52 | -24.07 | -20.1086048454 | 119.7 | 134.63 | 94.48 | 9391185 | 115.69278643 | CS |
| 156 | 15.86 | 19.8821612135 | 79.77 | 134.63 | 72.875 | 9131860 | 104.17594785 | CS |
| 260 | 6.84 | 7.70357022187 | 88.79 | 134.63 | 65.25 | 10114220 | 92.33294657 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
